Clorox chief executive officer and director Linda J. Rendle acquired 29,352 common shares through settlement of a 2023 Performance Unit Grant that vested October 5, 2026; she elected to defer the settlement under the 2005 Stock Incentive Plan. On that date, Clorox withheld 692 shares for taxes relating to vesting performance stock units and 11,989 shares for taxes relating to vesting restricted stock.
Clorox (CLX) VP - CAO & Corp Controller Laurene E. Peck acquired 1,172 common shares on October 5, 2026, in settlement of a 2023 Performance Unit Grant that vested that day; she elected to defer the settlement under the 2005 Stock Incentive Plan. Clorox withheld 30 shares for tax obligations related to vesting performance stock units and 339 shares for tax obligations related to vesting restricted stock. Peck also held 100 shares indirectly through Trust of Parent.
Clorox Co. (CLX) EVP - Chief Admin Officer Kirsten Marriner acquired 6,637 common shares in settlement of a 2023 Performance Unit Grant that vested October 5, 2026. The company withheld 1,951 shares for taxes relating to vesting performance stock units and 2,142 shares for taxes relating to vesting restricted stock. A note tied to the restricted-stock entry says the resulting amount includes 721 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan. Each transaction entry lists $80.41 per share.
Clorox COO Chris T. Hyder reported acquiring 4,191 common shares through settlement of a 2023 Performance Unit Grant that vested October 5, 2026. Hyder elected to defer the settlement pursuant to the 2005 Stock Incentive Plan. The report also lists 100 shares withheld for tax obligations related to performance-stock-unit vesting and 1,532 shares withheld for tax obligations related to restricted-stock vesting, each at $80.41 per share.
Clorox Co. (CLX) EVP - Chief Legal Officer Angela C. Hilt reported acquiring 6,637 common shares on October 5, 2026, through settlement of a 2023 Performance Unit Grant that vested that day. The company withheld 2,296 shares for taxes on vested performance stock units and 2,351 shares for taxes on vesting restricted stock. A related footnote identifies 647 shares acquired through the company's Stock Incentive Plan dividend-reinvestment feature. A separate holding entry lists 669 shares indirectly held through a 401(k).
Clorox (CLX) EVP - Chief Financial Officer Luc Bellet reported the acquisition of 1,677 common shares upon settlement of a 2023 Performance Unit Grant that vested October 5, 2026. On that date, the company withheld 580 shares for taxes related to vesting performance stock units and 1,031 shares for taxes related to vesting restricted stock.
Clorox (CLX) officer Nina Barton, listed with the title “EVP-Chief Growth & Strategy Of,” had 1,106 common shares withheld by the company on October 5, 2026, to satisfy tax obligations relating to vesting of restricted stock. The reported price was $80.41 per share. Her directly held common-stock position afterward was 36,179 shares, including 121 shares acquired through the company’s Stock Incentive Plan dividend reinvestment feature.
The Clorox Company (CLX) is seeking shareholder votes at its November 18, 2026 virtual annual meeting on 10 director nominees, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The Board recommends voting FOR each nominee and FOR both other proposals. Shareholders of record on September 21, 2026 are eligible to vote.
For fiscal 2026, Clorox reported net sales of $6.7 billion, down 5% from fiscal 2025; net earnings attributable to Clorox of $587 million, down 28%; and gross margin of 42.3%, down 290 basis points. The short-term incentive multiplier was 54%, and performance share units for the 2024–2026 period paid out at 69%. Clorox completed its GOJO acquisition in April 2026, acquired the remaining interest in its Glad bags and wraps joint venture, and completed its U.S. ERP implementation. The Board is searching for a successor to Linda Rendle, who will remain Chair and CEO until a successor is appointed and then serve in an advisory role for a period.
Clorox (CLX) director Christopher J. Williams acquired 339.4642 deferred stock units on September 30, 2026, in lieu of quarterly director's fees, and 276.2573 units on August 28, 2026, through dividend reinvestment under the Independent Directors' Deferred Compensation Plan. His reported direct common-stock holding was 849 shares as of September 30, 2026. The deferred units will be settled 100% in Clorox stock in connection with his retirement or other termination of service as a director.